D-0531-2025 Class II Ongoing
FDA drug recall D-0531-2025 was initiated by Advanced Pharmaceutical Technology, Inc. on May 30, 2025 and is designated Class II. Reason for recall: Marketed Without an Approved NDA/ANDA The recall status is ongoing. Affected quantity: 26 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 2, 2025
- Initiation Date
- May 30, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 26 vials
Product description
TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01
Reason for recall
Marketed Without an Approved NDA/ANDA
Distribution pattern
NY, NJ
Code information
Lot P-24-1; Exp. 02/28/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0531-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026